Recent reports suggest that a new drug is proposed to be more efficient in treating adults who have been recently tested HIV-positive in comparison to the previously used drugs.

It has been detailed that the new drug is a combination of three antiretroviral (ARTs) alongside a booster molecule, which has to be taken only once in a day. However, the treatment is best suitable for those, who have not had taken any treatment for the condition. In case of patients, subjected to other treatment, the consumption of the pill is increased from once to many times in a single day.

It has been reported that two different trials for the drug Quad were conducted at an international level. The results of the trials will be published on Friday in Lancet.

The findings of the trial suggest: "Quad pill is faster acting, doesn't have the neuropsychiatric side-effects associated with other combinations, and could improve compliance with treatment".

However, it has been warned that the patients have to be very careful regarding the medication, they have to be highly alert that they don't miss any of the doses; else the medication will not remain effective due to resistance of the virus.